Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.
Koneksa Health is a healthcare data analytics company that helps researchers incorporate emerging technologies into their clinical studies.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
A platform technology that is revolutionising healthcare by increasing the accessibility and diagnostic capability of non-invasive testing
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
SaaS AI/ML platform providing real-time voice and telecare to people with neurological disorders
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Dopavision is a therapeutic company developing a digital therapeutic for myopia.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
RxLightning automates the manual enrollment process of starting a patient on specialty medications.
Patientory is a patient data platform that empowers individuals to control their health data and earn personalized rewards.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Transforming medical data into predictive algorithms without code
FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.
Xealth is a digital health platform that enables healthcare organizations to prescribe and monitor health tools, programs, and services.
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.
Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely.
Novartis has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novartis's top investment sectors include Health Care, Biotechnology, Life Science, Therapeutics, Software. The firm invests across 29 different industry categories.
Among tracked funding rounds, Freenome received $240.0M in a Post-IPO Equity round. Novartis's total known invested capital is $3.9B.
Novartis's average investment size is $60.0M across its portfolio of 101 companies.
Recent Novartis portfolio additions include Renovacor, Aktis Oncology, Hyku, Koneksa Health, Poseida Therapeutics. These companies were founded in 2020 or later.